Latest Breaking News On - Microbiome movement drug development summit europe - Page 1 : comparemela.com

4D pharma plc: 4D pharma to Participate in 5th Microbiome Movement Drug Development Summit Europe 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs) a novel class of drug derived from the microbiome, today announced its participation in the Microbiome Movement Drug Development Summit Europe, including the Plenary Session, Microbiome Leaders Industry Review Panel. Plenary Session: European Microbiome Leaders Panel Discussion on Thursday, January 28, 2021 at 8:00am GMT (3:00am ET) with Chief Scientific Officer, Dr. Alex Stevenson, Ph.D. Clinical Trial Design and Evaluating PK/PD Session: MicroRx and Single Strain Live Biotherapeutics: Proof of Concept Clinical Data and Future Considerations on Thursday, January 28, 2021 at 11:30pm GMT (6:30am ET) with Research Director, Dr. Imke Mulder

United statesJulie seidelImke mulderDominic wilson phil walkerAlex stevensonDuncan peytonMerck co incBryan garnier coStern investor relations incEuropean microbiome leaders panel discussion onMicrobiome leaders industry review panelMicrobiome movement drug development summit europePlenary sessionMicrobiome leaders industry reviewEuropean microbiome leaders panel discussionChief scientific officer